The one-dose COVID-19 vaccine was accepted by US well being authorities on Friday, strengthening the nation’s combat in opposition to the pandemic.
Australian Nationwide College infectious illnesses doctor, Professor Sanjaya Senanayake stated the vaccine could possibly be one other good choice for Australia to endorse.
“There is not any purpose why we won’t use it,” he instructed Immediately.
Johnson & Johnson single-dose vaccine accepted by US. (AP)
“It’s kind of just like the AstraZeneca vaccine – makes use of an adenovirus to ship the genetic materials for the spike protein.
“After they gave a second dose within the part one and two research it did even higher.”
The vaccine will be saved between two to eight levels Celsius, making storage simpler than the Pfizer vaccine, which requires sub-zero refrigeration.
About 30,000 frontline staff acquired the Pfizer jab final week, with the nation falling behind on its vaccine goal.
US-approved Johnson & Johnson vaccine could possibly be viable choice for Australia, an skilled says. (9)
There have been roughly 6000 vaccine doses administered per day, which would want to ramp as much as about 150,000 a day for majority of Australians to be vaccinated by the tip of the yr.
Professor Senanayake stated he was not “nervous” in regards to the delay, nonetheless he believed the unique October goal appeared unlikely.
“That is going to take a very long time,” he stated.
“You wish to iron out wrinkles at first so that you begin off sluggish and construct issues up.”
College of Queensland infectious illness skilled Dr Paul Griffin admitted it was a “disappointing” the vaccine rollout was not on time.
“It’s a little bit disappointing we’ve not been in a position to hit the bottom working,” he instructed Immediately.
“We wish to get this proper and we’re in a extremely good place having learnt from some minor errors within the first week.”
Dr Griffin stated the doses could possibly be prepared to be used as early as subsequent week, serving to the nation transfer “full velocity” forward on the rollout.
Australia has secured 54 milion doses of the AstraZeneca vaccine, with 50 million to be made on residence soil in Melbourne.
“I believe that they’re getting near be being prepared … that places us in an excellent place to have a protected vaccine that may be manufactured in our nation,” Dr Griffin stated.
“As soon as that occurs, we will probably be actually in a position to ramp up our vaccination marketing campaign.”